ClinicalTrials.Veeva

Menu

Study to Investigate the Treatment Benefit of Probiotic Lactobacillus Crispatus M247 in Women Undergoing Homologous Level 2 Assisted Reproductive Technology (ART) Procedures

D

Dr. Amjad Khan

Status

Completed

Conditions

Fertility Issues

Treatments

Dietary Supplement: Probiotic Lactobacillus crispatus M247

Study type

Interventional

Funder types

Other
NETWORK

Identifiers

NCT05871242
LUMHS/REC/-253

Details and patient eligibility

About

The present study is aimed to explore the treatment effect from the intake of probiotic Lactobacillus crispatus M247 in the improvement of clinical and psychological aspects in women undergoing homologous level 2 ART procedures.

Full description

The use of assisted reproductive technology (ART) has increased dramatically worldwide due to the continuous rise in infertility rates; for these reasons an increasing number of couples undertake the path of ART, even though this is difficult journey, with uncertain outcomes and possible medical risks, both physical and psychological.

In this study the investigators aim to explore the hypothesis that recreating a favorable vaginotype through the intake of the probiotic Lactobacillus crispatus M247 can have a positive effect in achieving pregnancy in cryopreserved cycles as well as a positive relationship between vaginal, endometrial (still unknown), gut and oral microbiota.

Enrollment

160 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women undergoing homologous level 2 assisted reproductive technology (ART) procedures
  • Cryopreserved oocytes
  • D3 embryos
  • D5 blastulae
  • Age 18-45

Exclusion criteria

  • Presence of submucous uterine myomas.
  • Uterine malformations.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

160 participants in 2 patient groups

Treatment arm
Experimental group
Description:
Treatment with Lactobacillus crispatus M247
Treatment:
Dietary Supplement: Probiotic Lactobacillus crispatus M247
Control arm
No Intervention group
Description:
No Probiotic treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems